The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHansard Regulatory News (HSD)

Share Price Information for Hansard (HSD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.20
Bid: 49.20
Ask: 53.00
Change: 0.90 (1.79%)
Spread: 3.80 (7.724%)
Open: 52.00
High: 52.00
Low: 49.20
Prev. Close: 50.20
HSD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 Jan 2023 07:00

RNS Number : 4709N
Hansard Global plc
23 January 2023
 

 23 January 2023

Hansard Global plc (the "Company")

Appointment of Independent Non-Executive Director

&

Appointment of Chief Financial Officer and Executive Director

 

Following a process led by the Nominations Committee, and supported by an independent executive search firm, the Company is pleased to announce the appointment of Dr Christine Theodorovics as an Independent Non-Executive Director of the Company with effect from 23 January 2023.

Christine has more than 25 years' experience in financial services, most recently at AXA Group and prior to that, Zurich Insurance Group. She has a proven track record in management, business transformation, distribution, and strategic development across various senior positions in several countries.

Philip Kay, Chairman of the Board, commented: 

"On behalf of the Board, I would like to welcome Christine as an Independent Non-Executive Director. The Company will greatly benefit from the breadth of experience that she brings from a number of different areas including insurance. Christine's appointment will complement the Board and support the Hansard Group's commitment to increasing international experience at the highest level."

No information is required to be disclosed under Listing Rule 9.6.13R in respect of Dr Theodorovics' appointment.

The Company is also pleased to announce the appointment of Thomas Morfett as Chief Financial Officer (CFO) and Executive Director of the Group and its subsidiaries. Thomas joins from Utmost (Quilter) where he was Financial Controller and Head of Actuarial. This appointment will be effective as of the date that Thomas joins the Company on the expiry of his notice period. This follows the announcement made on 23 November 2022 of Tim Davies' intention to retire. Tim will remain with the Company until 12 May 2023 in order to oversee a period of transition.

Thomas is a Chartered Accountant and Actuary and has close to 20 years' experience in the life assurance industry, most recently at Utmost (Quilter) and previously Canada Life and Zurich. He has extensive financial, commercial, M&A and business transformation experience.

Graham Sheward, Chief Executive Officer, commented:

"I'm looking forward to working with Thomas as part of our executive team and as a fellow director on the Hansard Group Boards. As Chief Financial Officer, Thomas brings a highly complementary skillset to the Company and is ideal to support our strategic business development objectives."

No information is required to be disclosed pursuant to Listing Rule 9.6.13R in respect of Mr Morfett's appointment.

 

 

 

Enquiries:

Hansard Global plc +44 (0) 1624 688 000

Graham Sheward, Group Chief Executive Officer

Hazel Stewart, Company Secretary

Email: investor-relations@hansard.com

Camarco +44 (0) 7990 653 341

Ben Woodford, Hugo Liddy

 

LEI number: 213800ZJ9F2EA3Q24K05

 

Notes to editors:

· Hansard Global plc is the holding company of the Hansard Group of companies. The Company was listed on the London Stock Exchange in December 2006. The Group is a specialist long-term savings provider, based in the Isle of Man.

· The Group offers a range of flexible and tax-efficient investment products within a life assurance policy wrapper, designed to appeal to affluent, international investors.

· The Group utilises a controlled cost distribution model via a network of independent financial advisors and the retail operations of certain financial institutions who provide access to their clients in more than 170 countries. The Group's distribution model is supported by Hansard OnLine, a multi-language internet platform, and is scalable.

· The principal geographic markets in which the Group currently services contract holders and financial advisors are the Middle East & Africa, the Far East and Latin America. These markets are served by Hansard International Limited and Hansard Worldwide Limited.

 

· Hansard Europe dac previously operated in Western Europe but closed to new business with effect from 30 June 2013.

· The Group's objective is to grow by attracting new business and positioning itself to adapt rapidly to market trends and conditions. The scalability and flexibility of the Group's operations allow it to enter or develop new geographic markets and exploit growth opportunities within existing markets without the need for significant further investment.

 

The information contained in this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (Regulation 596/2014), as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABSGDBDBDDGXD
Date   Source Headline
22nd Apr 20249:36 amRNSBlock listing Interim Review
7th Mar 20247:05 amRNSResults for the six months ended 31 December 2023
15th Feb 20247:00 amRNSDirectorate Change
8th Nov 202311:55 amRNSResult of AGM
23rd Oct 20237:24 amRNSBlock listing Interim Review
28th Sep 202311:42 amRNSResults for the year ended 30 June 2023
28th Sep 20237:00 amRNSResults for the year ended 30 June 2023
27th Jul 20237:00 amRNSNew business results for the year ended 30/06/2023
23rd May 20239:27 amRNSDirector/PDMR Shareholding
4th May 20237:00 amRNSTrading Statement
20th Apr 20233:01 pmRNSBlock listing Interim Review
9th Mar 20237:00 amRNSResults for the six months ended 31 December 2022
26th Jan 20237:00 amRNSNew business results for 6 months ended 31/12/22
23rd Jan 20237:00 amRNSDirectorate Change
23rd Nov 20227:00 amRNSDirectorate Change
3rd Nov 20227:00 amRNSTrading update for the quarter ended 30/09/2022
2nd Nov 202212:22 pmRNSResult of AGM
25th Oct 20224:41 pmRNSSecond Price Monitoring Extn
25th Oct 20224:36 pmRNSPrice Monitoring Extension
20th Oct 202211:18 amRNSBlock listing Interim Review
5th Oct 20224:36 pmRNSPrice Monitoring Extension
26th Sep 20224:41 pmRNSSecond Price Monitoring Extn
26th Sep 20224:36 pmRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSResults for the year ended 30 June 2022
21st Jul 20227:00 amRNSNew business results for the year ended 30/06/2022
20th May 202211:59 amRNSPDMR Shareholding
5th May 20227:00 amRNSTrading update for the period ended 31 March 2022
22nd Apr 20228:30 amRNSBlock listing Interim Review
25th Mar 20229:54 amRNSListing Rule 9.6.14(R) Disclosure
3rd Mar 20227:05 amRNSAppointment of Chairman
3rd Mar 20227:00 amRNSResults for the six months ended 31 December 2021
27th Jan 20227:00 amRNSNew business results for 6 months ended 31/12/2021
17th Dec 20214:41 pmRNSSecond Price Monitoring Extn
17th Dec 20214:36 pmRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
8th Nov 20214:36 pmRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSTrading update
3rd Nov 20211:15 pmRNSResult of AGM
22nd Oct 20212:01 pmRNSBlock listing Interim Review
23rd Sep 20217:00 amRNSResults for the year ended 30 June 2021
24th Aug 20214:40 pmRNSSecond Price Monitoring Extn
24th Aug 20214:35 pmRNSPrice Monitoring Extension
20th Aug 20214:40 pmRNSSecond Price Monitoring Extn
20th Aug 20214:35 pmRNSPrice Monitoring Extension
17th Aug 20214:40 pmRNSSecond Price Monitoring Extn
17th Aug 20214:35 pmRNSPrice Monitoring Extension
22nd Jul 20217:00 amRNSNew business results for year ended 30 June 2021
20th Jul 202112:30 pmRNSDirector/PDMR Shareholding
16th Jul 20214:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.